News

BlogsPosts
As Seen In
Canadian Technology and Innovation: making strides in the global cell therapy landscape
Another cell therapy rising star, RepliCel Life Sciences, is harnessing the
BlogsPosts
As Seen In
Company Uses Patients' Own Cells to Put an End to Baldness, Aging Skin and Tendon Degeneration
Company Uses Patients' Own Cells To Put An End To Baldness, Aging Skin And Tendon
BlogsPosts
As Seen In
Regenerative medicine: Interview with a game-changing leader
Regenerative medicine is a game-changing area of medicine. It has the potential to fully heal
BlogsPosts
As Seen In
Your Hair Follicles May Hold the Key to Younger Looking Skin
Click here to read the full article as
BlogsPosts
Press Release
Prominent Skin Aging Researcher Provides Insights into RepliCel’s Clinical Data
“We believe that this novel therapy has the potential to rejuvenate skin in a way
BlogsPosts
As Seen In
Skin in the Game
To read the full article as it appears on DDN News (08/08/17), click here.
BlogsPosts
As Seen In
Poised for Success with Positive Clinical Results
To read the full interview as it appears on Costmeticosbr.com.br, click here (7/6/17).
BlogsPosts
As Seen In
Your Hair Could Hold The Secret To Mending Your Injured Tendon
To read the full article as it appears on Pridenews.ca , click here
BlogsPosts
As Seen In
The Latest in Biocellular Regeneration
To read the full article as it appears on TheAestheticChannel.com by Lisette Hilton, click here
BlogsPosts
As Seen In
Pioneer in Both Biotech & Business Left Noteworthy Legacy
To read the full article as it appears on HuffingtonPost.com by contributing editor, Lee Buckler,
BlogsPosts
As Seen In
Exclusive Interview with RepliCel Life Sciences President and CEO Lee Buckler
To read the full article as it appears on SmarterAnalyst.com by Julie Lamb, click here.
BlogsPosts
As Seen In
Cell therapy: Scientific breakthrough treats signs of ageing
To read the full article as it appears on Cosmetics design-asia.com by Natasha Spencer, click
BlogsPosts
As Seen In
RepliCel Developing Autologous Cell Therapies For Skin, Hair and Tendon Regeneration
To read the full interview as it appears on MedicalResearch.com, click here. (4/22/17)
BlogsPosts
As Seen In
String of Positive Trial Results Boosts RepliCel’s Profile
To read the full article as it appears on thelifesciencesreport.com, click here. (04/12/17)
BlogsPosts
As Seen In
RepliCel – Stem Cell Therapies Using Your Own Cells
To listen to Podcast and View Transcript on Future Tech Podcast, click here
BlogsPosts
Press Release
Positive Results from RepliCel’s RCS-01 Phase I Skin Trial are the Company’s Most Compelling to Date
Interim trial results lead researchers to conclude that the injection of RCS-01 is not only
BlogsPosts
As Seen In
Will 2017 be the year of Cell Therapies?
To read the full article as it appears on The Huffington Post, click here. (1/20/17) While
BlogsPosts
As Seen In
RepliCel – Using Cells for Healing
View featured company Article on Advisor Access click here
BlogsPosts
As Seen In
RepliCel CEO Lee Buckler talks to Cantech Letter
View Article by Nick Waddell on Cantech Letter click here
BlogsPosts
Press Release
RepliCel Life Sciences conducts formal consultation review with Japan’s PMDA and receives unprecedented review fee reduction
Japan’s Pharmaceuticals and Medical Devices Agency reviews RepliCel’s pre-clinical, quality, and manufacturing data for its

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.